AI-Bolstered Drug Co. Hits Ch. 11 With $105M Debt
A company that uses artificial intelligence to explore new uses for existing drugs entered bankruptcy in Delaware with over $104 million in debt and a stalking horse bidder....To view the full article, register now.
Already a subscriber? Click here to view full article